KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Assets Average (2016 - 2025)

Pfizer (PFE) has disclosed Assets Average for 17 consecutive years, with $208.4 billion as the latest value for Q4 2025.

  • Quarterly Assets Average fell 3.69% to $208.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $208.4 billion through Dec 2025, down 3.69% year-over-year, with the annual reading at $210.8 billion for FY2025, 2.61% down from the prior year.
  • Assets Average for Q4 2025 was $208.4 billion at Pfizer, roughly flat from $207.4 billion in the prior quarter.
  • The five-year high for Assets Average was $223.8 billion in Q1 2024, with the low at $108.1 billion in Q4 2021.
  • Average Assets Average over 5 years is $185.3 billion, with a median of $207.2 billion recorded in 2025.
  • The sharpest move saw Assets Average fell 6.23% in 2021, then surged 85.24% in 2023.
  • Over 5 years, Assets Average stood at $113.9 billion in 2021, then rose by 4.62% to $119.2 billion in 2022, then soared by 85.24% to $220.8 billion in 2023, then fell by 1.95% to $216.4 billion in 2024, then dropped by 3.69% to $208.4 billion in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $208.4 billion, $207.4 billion, and $207.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.